[#item_full_content]
Year: 2025
Circle Pharma to Present Trials in Progress Poster on CID-078, a First-in-Class Cyclin A/B Inhibitor, at the ASCO 2025 Annual Meeting
[#item_full_content]SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)– #ASCO2025–Circle Pharma, a clinical-stage biopharmaceutical company advancing macrocycle therapeutics for difficult-to-treat…